Revenue Increases 64% to $31.8 Million Compared to $19.3 Million in Q1 2021
Adjusted EBITDA is $7.9 Million, 25% of Revenue
14 Dispensaries Added During Q1 2022 in Colorado and New Mexico
On Track to Achieve Guidance Q4 2022 Projected Revenue Annualized Run Rate of Approximately $220 Million - $260 Million Q4 2022 Projected Adjusted EBITDA Annualized Run Rate of Approximately $70 Million - $82 Million
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.